{"id":"autologous-monocytes","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Infection"}]},"_chembl":{"chemblId":"CHEMBL5315092","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This cell therapy leverages the patient's own monocytes—innate immune cells with roles in inflammation, phagocytosis, and tissue remodeling—by harvesting them, processing them (potentially with activation or differentiation signals), and returning them to the patient to augment immune responses or promote healing. The mechanism likely involves enhanced antimicrobial activity, clearance of damaged tissue, and secretion of immunomodulatory cytokines.","oneSentence":"Autologous monocytes are a patient's own immune cells that are isolated, potentially modified or activated ex vivo, and reinfused to enhance immune function and promote tissue repair.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:02:59.073Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Diabetic foot ulcers (Phase 3)"}]},"trialDetails":[{"nctId":"NCT06839326","phase":"NA","title":"Efficacy of Autologous Conditioned Serum in Temporomandibular Joint Disorder","status":"COMPLETED","sponsor":"Batman University","startDate":"2024-11-01","conditions":"Temporomandibular Joint Osteoarthritis","enrollment":75},{"nctId":"NCT04335890","phase":"PHASE1","title":"IKKb-matured, RNA-loaded Dendritic Cells for Metastasised Uveal Melanoma","status":"COMPLETED","sponsor":"Hasumi International Research Foundation","startDate":"2020-09-24","conditions":"Melanoma, Uveal Metastatic","enrollment":17},{"nctId":"NCT02948426","phase":"PHASE1","title":"Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-02-08","conditions":"Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer","enrollment":18},{"nctId":"NCT07020715","phase":"PHASE2","title":"A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2026-03-01","conditions":"Multiple Sclerosis","enrollment":14},{"nctId":"NCT00534469","phase":"PHASE2","title":"Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R","status":"COMPLETED","sponsor":"City of Hope Medical Center","startDate":"2000-02-08","conditions":"Leukemia","enrollment":60},{"nctId":"NCT05052957","phase":"PHASE2","title":"hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)","status":"RECRUITING","sponsor":"Leland Metheny","startDate":"2023-01-20","conditions":"Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma","enrollment":16},{"nctId":"NCT05029336","phase":"PHASE2","title":"Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases","status":"RECRUITING","sponsor":"Stephan Grupp MD PhD","startDate":"2026-03","conditions":"Systemic Lupus Erythematosus, Systemic Sclerosis","enrollment":20},{"nctId":"NCT07151703","phase":"PHASE3","title":"Topical Versus Injection PRP for Olfactory Dysfunction","status":"NOT_YET_RECRUITING","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2025-10-01","conditions":"Olfactory Dysfunction, Anosmia, Hyposmia","enrollment":60},{"nctId":"NCT05304208","phase":"PHASE1","title":"dENdritic Cell Therapy Combined With SURgEry in Mesothelioma","status":"RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2021-11-02","conditions":"Mesotheliomas Pleural","enrollment":16},{"nctId":"NCT06707389","phase":"EARLY_PHASE1","title":"Autologous Blood Monocyte Vesicles for the Treatment of Sudden Deafness","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2024-12-25","conditions":"Sudden Deafness, Sensorineural Hearing Loss","enrollment":30},{"nctId":"NCT06254807","phase":"PHASE1","title":"CAR-monocytes for the Treatment of HER2 Overexpressing Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Carisma Therapeutics Inc","startDate":"2024-01-08","conditions":"HER2-positive","enrollment":6},{"nctId":"NCT06694168","phase":"NA","title":"Efficacy of the Entire Papilla Preservation Technique With and Without the Use of L-PRF as a Regenerative Material for the Treatment of Infrabony Defects","status":"RECRUITING","sponsor":"Universidad de los Andes, Chile","startDate":"2024-08-27","conditions":"Periodontal Regeneration, Minimally Invasive Surgical Technique, Platelet Rich Fibrin","enrollment":30},{"nctId":"NCT05882305","phase":"EARLY_PHASE1","title":"KSD-101 Therapy for EBV-associated Lymphomas: an Exploratory Clinical Trial","status":"WITHDRAWN","sponsor":"Kousai Bio Co., Ltd.","startDate":"2023-06-10","conditions":"EBV-associated Lymphomas","enrollment":""},{"nctId":"NCT01446731","phase":"PHASE2","title":"Dendritic Cell Vaccination and Docetaxel for Patients With Prostate Cancer","status":"COMPLETED","sponsor":"Inge Marie Svane","startDate":"2011-10","conditions":"Prostatic Neoplasms","enrollment":43},{"nctId":"NCT06431529","phase":"EARLY_PHASE1","title":"A Study of Tumor Neoantigen-specific T Cells in the Treatment of Advanced Solid Tumors","status":"RECRUITING","sponsor":"JIANG LONGWEI","startDate":"2024-04-18","conditions":"Tumor, Solid","enrollment":6},{"nctId":"NCT02546102","phase":"PHASE3","title":"Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma","status":"SUSPENDED","sponsor":"Precision Life Sciences Group","startDate":"2024-12","conditions":"Glioblastoma Multiforme","enrollment":234},{"nctId":"NCT06097793","phase":"EARLY_PHASE1","title":"KSD-101 Therapy for EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial","status":"RECRUITING","sponsor":"Kousai Bio Co., Ltd.","startDate":"2023-12-04","conditions":"Nasopharyngeal Carcinoma","enrollment":12},{"nctId":"NCT03610360","phase":"PHASE2, PHASE3","title":"DENdritic Cell Immunotherapy for Mesothelioma","status":"COMPLETED","sponsor":"Amphera BV","startDate":"2018-06-21","conditions":"Mesothelioma","enrollment":176},{"nctId":"NCT06224738","phase":"EARLY_PHASE1","title":"Human HER2-targeted Macrophages Therapy for HER2-positive Advanced Gastric Cancer With Peritoneal Metastases","status":"UNKNOWN","sponsor":"First People's Hospital of Hangzhou","startDate":"2024-03-01","conditions":"Gastric Cancer","enrollment":9},{"nctId":"NCT01352858","phase":"PHASE1","title":"Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis (AutoDECRA)","status":"COMPLETED","sponsor":"Newcastle University","startDate":"2012-02","conditions":"Rheumatoid Arthritis","enrollment":14},{"nctId":"NCT05650918","phase":"PHASE1","title":"MesoPher/Mitazalimab-combination Therapy in Metastatic Pancreatic Disease (REACtiVe-2 Trial)","status":"COMPLETED","sponsor":"Joachim Aerts, MD PhD","startDate":"2021-08-30","conditions":"Metastatic Pancreatic Cancer","enrollment":22},{"nctId":"NCT05635591","phase":"PHASE1","title":"KSD-101 Therapy for EBV-associated Haematologic Neoplasms: an Exploratory Clinical Trial","status":"UNKNOWN","sponsor":"Tongji Hospital","startDate":"2023-01-16","conditions":"EBV-associated Haematologic Neoplasms","enrollment":9},{"nctId":"NCT02903537","phase":"PHASE1","title":"Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS)","status":"UNKNOWN","sponsor":"Fundació Institut Germans Trias i Pujol","startDate":"2017-07-06","conditions":"Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Chronic Progressive","enrollment":16},{"nctId":"NCT03803397","phase":"PHASE1","title":"Arm 1: Lysate Pulsed Dendritic Cells (PV-001-DC) in Patients With Melanoma","status":"UNKNOWN","sponsor":"PrimeVax Immuno-Oncology Inc.","startDate":"2024-04-01","conditions":"Metastatic Melanoma","enrollment":10},{"nctId":"NCT03990493","phase":"PHASE1","title":"Intratumoral Injection of PV-001-DV Plus DC in Patients With Melanoma","status":"UNKNOWN","sponsor":"PrimeVax Immuno-Oncology Inc.","startDate":"2024-04-01","conditions":"Advanced Melanoma","enrollment":10},{"nctId":"NCT05100641","phase":"PHASE3","title":"AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM","status":"NOT_YET_RECRUITING","sponsor":"Aivita Biomedical, Inc.","startDate":"2024-01","conditions":"Primary Glioblastoma","enrollment":672},{"nctId":"NCT02866006","phase":"PHASE1, PHASE2","title":"Safety and Tolerability Evaluation Study of BVAC-C in Patients With HPV Type 16 or 18 Positive Cervical Cancer","status":"COMPLETED","sponsor":"Cellid Co., Ltd.","startDate":"2016-10","conditions":"Uterine Cervical Neoplasms","enrollment":32},{"nctId":"NCT01946373","phase":"PHASE1","title":"T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma","status":"UNKNOWN","sponsor":"Karolinska University Hospital","startDate":"2013-10","conditions":"Melanoma","enrollment":20},{"nctId":"NCT01730118","phase":"PHASE1","title":"Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2013-03-04","conditions":"Breast Neoplasms, Breast Cancer, Adenocarcinomas","enrollment":33},{"nctId":"NCT05059821","phase":"PHASE1","title":"Personalized Cancer Vaccine in Egyptian Cancer Patients","status":"UNKNOWN","sponsor":"zeinab ahmed yousif hasan ashour","startDate":"2021-04-19","conditions":"Hepatocellular Carcinoma","enrollment":10},{"nctId":"NCT02033616","phase":"PHASE2","title":"Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas","status":"UNKNOWN","sponsor":"Aivita Biomedical, Inc.","startDate":"2017-11-18","conditions":"Stage III Ovarian Carcinoma, Stage IV Ovarian Carcinoma, Fallopian Tube Carcinoma","enrollment":99},{"nctId":"NCT02362451","phase":"PHASE2","title":"Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2015-07-10","conditions":"Prostatic Neoplasms, Prostate Cancer","enrollment":7},{"nctId":"NCT05251870","phase":"PHASE1, PHASE2","title":"Tolerogenic Dendritic Cell Therapy for Rheumatoid Arthritis","status":"UNKNOWN","sponsor":"UMC Utrecht","startDate":"2021-08-17","conditions":"Rheumatoid Arthritis","enrollment":18},{"nctId":"NCT04834544","phase":"PHASE2","title":"A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care","status":"RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2021-04-19","conditions":"Epithelial Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma","enrollment":75},{"nctId":"NCT04805086","phase":"PHASE1, PHASE2","title":"The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19","status":"UNKNOWN","sponsor":"Guy's and St Thomas' NHS Foundation Trust","startDate":"2021-03-08","conditions":"Pulmonary Fibrosis, Interstitial Lung Disease, Covid19","enrollment":5},{"nctId":"NCT03514836","phase":"PHASE1, PHASE2","title":"A Phase I/II, Safety Clinical Trial of DCVAC/PCa and ONCOS-102 in Men With Metastatic Castration-resistant Prostate Cancer","status":"TERMINATED","sponsor":"SOTIO a.s.","startDate":"2018-05-23","conditions":"Castration-resistant Prostate Cancer","enrollment":5},{"nctId":"NCT04184232","phase":"PHASE2","title":"Treatment of Recurrent Bladder Cancer With Dendritic Cells","status":"COMPLETED","sponsor":"Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus","startDate":"2019-07-01","conditions":"Bladder Cancer","enrollment":17},{"nctId":"NCT03425773","phase":"PHASE1","title":"Safety and Tolerability Evaluation Study of BVAC-B in Patients With HER2/Neu(Human Epithelial Growth Factor Receptor 2) Positive Gastric Cancer After Failure to Standard Care","status":"COMPLETED","sponsor":"Cellid Co., Ltd.","startDate":"2018-02-26","conditions":"Stomach Neoplasms","enrollment":8},{"nctId":"NCT03337165","phase":"PHASE1","title":"Autologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Russian Academy of Medical Sciences","startDate":"2016-12","conditions":"Musculoskeletal Diseases, Joint Disease, Arthritis","enrollment":10},{"nctId":"NCT02767193","phase":"PHASE1","title":"Safety and Immunogenicity of a Vaccine Dendritic Cell-based Pulsed With Autologous Heat-inactivated in HIV-1 Infected Patients","status":"COMPLETED","sponsor":"Judit Pich Martínez","startDate":"2016-05","conditions":"HIV Infection","enrollment":36},{"nctId":"NCT03119025","phase":"PHASE1, PHASE2","title":"Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection","status":"COMPLETED","sponsor":"Russian Academy of Medical Sciences","startDate":"2015-05","conditions":"Hepatitis C, Chronic, Liver Diseases, Hepatitis","enrollment":10},{"nctId":"NCT03390231","phase":"PHASE2","title":"Stem Cell Educator Therapy in Diabetes","status":"UNKNOWN","sponsor":"Throne Biotechnologies Inc.","startDate":"2017-11-27","conditions":"Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":100},{"nctId":"NCT00929019","phase":"PHASE1, PHASE2","title":"Messenger Ribonucleic Acid (mRNA) Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients","status":"TERMINATED","sponsor":"Radboud University Medical Center","startDate":"2009-06","conditions":"Uveal Melanoma","enrollment":23},{"nctId":"NCT00125749","phase":"PHASE1, PHASE2","title":"Vaccination of Patients With Stage IV Melanoma With Dendritic Cells","status":"COMPLETED","sponsor":"Baylor Research Institute","startDate":"2005-07","conditions":"Melanoma, Neoplasm Metastasis","enrollment":30},{"nctId":"NCT01530698","phase":"PHASE1, PHASE2","title":"Single-step Antigen Loading and TLR Activation of Dendritic Cells in Melanoma Patients","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2010-04","conditions":"Melanoma","enrollment":28},{"nctId":"NCT00940004","phase":"PHASE1, PHASE2","title":"Toll-like Receptor (TLR) Ligand Matured Dendritic Cell Vaccination in Melanoma Patients","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2009-06","conditions":"Melanoma","enrollment":20},{"nctId":"NCT01118013","phase":"PHASE2","title":"Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant","status":"TERMINATED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2010-12","conditions":"Leukemia, Lymphoma, Lymphoproliferative Disorder","enrollment":6},{"nctId":"NCT00377247","phase":"PHASE1","title":"Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous Tumor","status":"TERMINATED","sponsor":"University of Pittsburgh","startDate":"2009-04","conditions":"Primary Advanced Carcinoma of the Oral Cavity or Oropharynx, Squamous Cell Carcinoma of the Head and Neck","enrollment":5},{"nctId":"NCT00002768","phase":"PHASE2","title":"Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"1996-06","conditions":"Leukemia","enrollment":51},{"nctId":"NCT00698776","phase":"PHASE1","title":"Combination of Lenalidomide and Autologous Mature Dendritic Cells Pulsed With KRN7000 in Myeloma","status":"COMPLETED","sponsor":"Yale University","startDate":"2009-04","conditions":"Myeloma","enrollment":6},{"nctId":"NCT01213407","phase":"PHASE2","title":"Dendritic Cell Cancer Vaccine for High-grade Glioma","status":"COMPLETED","sponsor":"Activartis Biotech","startDate":"2010-04","conditions":"Glioblastoma Multiforme","enrollment":87},{"nctId":"NCT02533895","phase":"PHASE1","title":"Cancer Immune Therapy for the Treatment of Refractory Solid Tumours of Childhood","status":"COMPLETED","sponsor":"Activartis Biotech","startDate":"2000-02","conditions":"Childhood Solid Tumor","enrollment":67},{"nctId":"NCT00074230","phase":"PHASE1, PHASE2","title":"Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma","status":"COMPLETED","sponsor":"University Hospital Erlangen","startDate":"2003-07","conditions":"Melanoma (Skin)","enrollment":82},{"nctId":"NCT02395679","phase":"PHASE1","title":"Dendritic Cells Loaded With Allogeneous Cell Lysate in Mesothelioma Patients","status":"UNKNOWN","sponsor":"Erasmus Medical Center","startDate":"2015-01","conditions":"Mesothelioma","enrollment":9},{"nctId":"NCT01006044","phase":"PHASE2","title":"Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical Resection","status":"COMPLETED","sponsor":"Clinica Universidad de Navarra, Universidad de Navarra","startDate":"2009-10","conditions":"Glioblastoma Multiforme","enrollment":26},{"nctId":"NCT01241682","phase":"PHASE1","title":"Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma","status":"COMPLETED","sponsor":"Erasmus Medical Center","startDate":"2009-10","conditions":"Malignant (Pleural) Mesothelioma","enrollment":10},{"nctId":"NCT00672542","phase":"PHASE1","title":"Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells","status":"COMPLETED","sponsor":"Scott Pruitt","startDate":"2008-01","conditions":"Metastatic Melanoma, Absence of CNS Metastases","enrollment":12},{"nctId":"NCT00002658","phase":"PHASE3","title":"Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia","status":"UNKNOWN","sponsor":"Medical Research Council","startDate":"1994-01","conditions":"Leukemia, Neutropenia","enrollment":2000},{"nctId":"NCT00126685","phase":"PHASE1, PHASE2","title":"Vaccine Therapy in Treating Patients With Stage IV Melanoma","status":"UNKNOWN","sponsor":"Dermatologische Klinik MIT Poliklinik-Universitaetsklinikum Erlangen","startDate":"2005-04","conditions":"Melanoma (Skin)","enrollment":30},{"nctId":"NCT00002567","phase":"PHASE2","title":"High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in Remission","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"1994-03","conditions":"Bone Marrow Ablation, Leukemia","enrollment":45},{"nctId":"NCT00004899","phase":"PHASE2","title":"Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome","status":"COMPLETED","sponsor":"Northwestern University","startDate":"1999-10","conditions":"Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases","enrollment":""},{"nctId":"NCT00002945","phase":"PHASE3","title":"High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"1996-12","conditions":"Leukemia","enrollment":61},{"nctId":"NCT00963521","phase":"PHASE1","title":"Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia in Complete Remission","status":"COMPLETED","sponsor":"Institut Paoli-Calmettes","startDate":"2008-06","conditions":"Leukemia","enrollment":10},{"nctId":"NCT00004128","phase":"PHASE3","title":"Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia","status":"UNKNOWN","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"1999-09","conditions":"Leukemia","enrollment":2000},{"nctId":"NCT00002549","phase":"PHASE3","title":"Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia","status":"UNKNOWN","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"1993-11","conditions":"Leukemia","enrollment":1520},{"nctId":"NCT00003758","phase":"PHASE2","title":"Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia","status":"UNKNOWN","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"1998-12","conditions":"Leukemia","enrollment":60},{"nctId":"NCT00056758","phase":"PHASE1","title":"HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2003-02","conditions":"HIV Infections","enrollment":18},{"nctId":"NCT00223067","phase":"PHASE1","title":"Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor) With TAIZ-Monocytes","status":"UNKNOWN","sponsor":"University Hospital Schleswig-Holstein","startDate":"2005-03","conditions":"Renal Transplantation","enrollment":10}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":326,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Autologous monocytes","genericName":"Autologous monocytes","companyName":"Aivita Biomedical, Inc.","companyId":"aivita-biomedical-inc","modality":"Biologic","firstApprovalDate":"","aiSummary":"Autologous monocytes are a patient's own immune cells that are isolated, potentially modified or activated ex vivo, and reinfused to enhance immune function and promote tissue repair. Used for Diabetic foot ulcers (Phase 3).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}